Loading clinical trials...
Loading clinical trials...
Phase II Study of Nab-Paclitaxel and Ramucirumab for the Second-line Treatment of Patients With Metastatic Gastroesophageal Cancer
Conditions
Interventions
nab-paclitaxel
ramucirumab
Locations
11
United States
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Florida Cancer Specialists-South
Fort Myers, Florida, United States
Florida Hospital Cancer Institute
Orlando, Florida, United States
Florida Cancer Specialists-North
St. Petersburg, Florida, United States
Ingalls Cancer Research Center
Harvey, Illinois, United States
Research Medical Center
Kansas City, Missouri, United States
Start Date
May 5, 2015
Primary Completion Date
May 21, 2021
Completion Date
May 21, 2021
Last Updated
July 1, 2022
NCT06257264
NCT06253871
NCT05431738
NCT03610711
NCT05438940
NCT05632939
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions